当前位置:首页 - 行情中心 - 百洋医药(301015) - 财务分析 - 现金流量表

百洋医药

(301015)

  

流通市值:132.60亿  总市值:132.62亿
流通股本:5.26亿   总股本:5.26亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,418,769,007.922,244,391,700.748,301,581,715.216,304,553,603.47
  收到其他与经营活动有关的现金53,338,736.029,569,817.25138,096,365.7116,424,960.3
  经营活动现金流入小计4,472,107,743.942,253,961,517.998,439,678,080.916,420,978,563.77
  购买商品、接受劳务支付的现金3,039,804,569.871,597,214,977.614,745,735,338.443,771,991,577.06
  支付给职工以及为职工支付的现金356,536,238.98213,966,925.35707,241,369.1551,404,350.07
  支付的各项税费295,388,067.91116,082,734.08641,347,842.61451,986,423.21
  支付其他与经营活动有关的现金742,371,408.37303,780,054.341,410,899,925.91,024,178,648.22
  经营活动现金流出小计4,434,100,285.132,231,044,691.387,505,224,476.055,799,560,998.56
  经营活动产生的现金流量净额38,007,458.8122,916,826.61934,453,604.86621,417,565.21
二、投资活动产生的现金流量:
  收回投资收到的现金207,461,562.887,461,562.8340,000,000230,000,000
  取得投资收益收到的现金3,794,436.04602,436.727,701,860.36,771,532.94
  处置固定资产、无形资产和其他长期资产收回的现金净额2,5002,500402,699.429,134.4
  投资活动现金流入小计211,258,498.8488,066,499.52348,104,559.7236,800,667.34
  购建固定资产、无形资产和其他长期资产支付的现金87,041,084.8546,316,225.16288,930,824.87198,271,915.12
  投资支付的现金459,222,976.16229,686,883.89647,979,490.24568,098,746.96
  投资活动现金流出小计546,264,061.01276,003,109.05936,910,315.11766,370,662.08
  投资活动产生的现金流量净额-335,005,562.17-187,936,609.53-588,805,755.41-529,569,994.74
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,170,783.88-980,000980,000
  其中:子公司吸收少数股东投资收到的现金9,170,783.88-980,000980,000
  取得借款收到的现金2,087,670,255.941,010,989,043.512,287,551,589.532,002,726,449.9
  收到其他与筹资活动有关的现金160,690,920.18101,026,990.31199,285,074.98231,979,024.82
  筹资活动现金流入小计2,257,531,9601,112,016,033.822,487,816,664.512,235,685,474.72
  偿还债务支付的现金1,627,068,281.28574,376,957.581,260,341,663.761,136,468,352.05
  分配股利、利润或偿付利息支付的现金346,497,846.5218,497,855.82502,768,596.16469,123,784.76
  其中:子公司支付给少数股东的股利、利润315,000315,00035,197,963.6518,539,459.65
  支付其他与筹资活动有关的现金190,638,414.7413,638,530.75359,227,598.78287,221,716.98
  筹资活动现金流出小计2,164,204,542.54606,513,344.152,122,337,858.71,892,813,853.79
  筹资活动产生的现金流量净额93,327,417.46505,502,689.67365,478,805.81342,871,620.93
四、汇率变动对现金及现金等价物的影响-9,515,962.26-4,424,046.32-9,730,307.46-6,340,154.17
五、现金及现金等价物净增加额-213,186,648.16336,058,860.43701,396,347.8428,379,037.23
  加:期初现金及现金等价物余额1,923,942,541.851,923,942,541.851,222,546,194.051,222,546,194.05
  期末现金及现金等价物余额1,710,755,893.692,260,001,402.281,923,942,541.851,650,925,231.28
补充资料:
  净利润279,948,368.1-571,929,272.87-
  资产减值准备9,402,741.89-54,727,812.82-
  固定资产和投资性房地产折旧33,124,868.16-62,929,049.04-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧33,124,868.16-62,929,049.04-
  无形资产摊销14,459,939.52-23,126,318.47-
  长期待摊费用摊销5,070,525.2-10,922,515.7-
  处置固定资产、无形资产和其他长期资产的损失-181,184.53--520,328.84-
  固定资产报废损失63,789.76-601,655.43-
  公允价值变动损失2,121,027.02--73,356,424.42-
  财务费用58,015,991.81-103,652,681.68-
  投资损失2,818,891.75--23,153,668.53-
  递延所得税-3,290,955.06--29,725,684.97-
  其中:递延所得税资产减少-2,662,626.6--28,683,000.91-
    递延所得税负债增加-628,328.46--1,042,684.06-
  存货的减少-290,439,960.67--11,685,641.22-
  经营性应收项目的减少310,904,622.04-150,190,559.2-
  经营性应付项目的增加-399,092,544.33-61,810,383.76-
  现金的期末余额1,697,575,165.59-1,912,084,455.36-
  减:现金的期初余额1,912,084,455.36-1,212,445,674.09-
  加:现金等价物的期末余额13,180,728.1-11,858,086.49-
  减:现金等价物的期初余额11,858,086.49-10,100,519.96-
  现金及现金等价物的净增加额-213,186,648.16-701,396,347.8-
公告日期2026-08-292026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑